Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” fourth quarter 2024 ...
One half of J&J’s treatment is Lazcluze, a pill that, like Astra’s Tagrisso, blocks a cancer-associated protein called EGFR.
AstraZeneca PLC AZN shares slid 1.34% to £114.52 Monday, on what proved to be an all-around rough trading session for the ...
AstraZeneca Plc will invest $2.5 billion in a new research center in Beijing, in a major show of commitment to China just ...
Wealthfront Advisers LLC acquired a new stake in AstraZeneca PLC (NASDAQ:AZN – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange ...
(Bloomberg) -- AstraZeneca Plc will invest $2.5 billion in a new research center in Beijing, in a major show of commitment to China just months after the company’s top executive there was ...
Shares of AstraZeneca PLC (LON:AZN – Get Free Report ... stock with a hold rating and five have given a buy rating to the company. The average 1 year target price among brokers that have ...
AstraZeneca Plc‘s win over shareholders who challenged its $3 billion sale of biotech firm Viela Bio Inc. was affirmed Wednesday by the Delaware Supreme Court.
AstraZeneca to acquire EsoBiotec to advance cell therapy ambition Acquisition includes world-leading in vivo delivery platform with potential to transform cell therapy AstraZeneca has ...
We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results